KAI Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 23
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $332M
Latest Deal Amount

KAI Pharmaceuticals General Information

Description

Developer of biopharmaceutical drugs. The company develops therapeutics targeting protein kinase C, a family of enzymes focusing cardiovascular and ischemic diseases, pain, cancer, diabetes and inflammation, as well as ocular angiogenesis. Its pharmaceutical agent is used for the treatment of secondary hyperparathyroidism.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 270 Littlefield Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KAI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 05-Jul-2012 $332M 0000 00000 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 02-May-2006 0000 0000 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 26-Oct-2004 $28M $28M 0000 Completed Product Development
To view KAI Pharmaceuticals’s complete valuation and funding history, request access »

KAI Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view KAI Pharmaceuticals’s complete cap table history, request access »

KAI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KAI Pharmaceuticals Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aberdare Ventures Venture Capital Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
InterWest Health Partners Venture Capital Minority 000 0000 000000 0
Intersouth Partners Venture Capital Minority 000 0000 000000 0
Kearny Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »